Posts tagged with ‘board’

  • Larry Fritz, PhD

    - by Syntrix

    Founder and CEO Incro Pharmaceuticals (recently acquired by Denali Therapeutics)
    Previously Founder and CEO at Covella Pharmaceuticals, Conforma Therapeutics and Cabrellis Pharmaceuticals, as well as Scientific Founder of Athena Neurosciences, IDUN Pharmaceuticals—all successfully sold.
    PhD (Biophysics) Rockefeller University

  • Mark Mendel, PhD

    - by Syntrix

    Senior Consultant, Broadmark Capital LLC
    Previously Co-Founder and Managing Director of RiverVest Venture Partners and Kauffman Fellow at ARCH Venture Partners
    Venture investor in Conforma Therapeutics, Xcyte Therapies, and CGI Pharmaceuticals
    PhD (Bioengineering) from U Pennsylvania

  • John A. Zebala, MD, PhD

    - by Syntrix

    MD and PhD (Molecular Biology) from Weill Cornell Medical School. Syntrix founder and architect of the company and its development strategy.